The stem cell assay market is estimated to be valued at US$ 1.6 Billion in 2022 and is expected to exhibit a CAGR of 16.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview:Stem cell assays are techniques used to study properties of stem cells such as differentiation, proliferation, apoptosis and more. These assays are...
Market Insights
Stem cells have been acknowledged for their promising potential toward the development of various cutting-edge treatments for a number of diseases. As such, stem cell assays have a rapidly growing market. Stem cell assays are essentially the techniques used for analyzing living cells by various parameters which ultimately help determine the biochemical and cellular...
Stem cells hold tremendous promise for developing new treatments and cures for devastating diseases. However, progress in this field relies on accurate and reliable methods for characterizing stem cells. Stem cell assay is a critical tool that allows researchers to study stem cells and develop safe and effective stem cell-based therapies.
What are Stem Cells?
Stem cells are unique cells...
Stem cells are basic units that can differentiate into specialized cell types in the body. They have two key properties - the ability to self-renew through cell division and the ability to differentiate into different cell types. There are three main types of stem cells - embryonic stem cells, adult stem cells, and induced pluripotent stem cells. Embryonic stem cells can develop into any type...
A stem cell assay is an analysis performed on stem cells for studying their characteristics and potential. Stem cell assays help evaluate stem cell viability, purity, potency, differentiation potential and other crucial parameters. They aid in various applications ranging from development of new stem cell therapies, drugs screening, toxicology testing and more. Stem cell-based therapies are...
The stem cell assays market is expected to grow at a CAGR of 17.7% during the forecast period. The growth of the market is projected to be driven by increasing funding for stem cell research, rising demand for cell-based assays in drug discovery, and the rising incidence of cancer across the globe.
The viability/cytotoxicity assays accounted for the largest share of the type segment in the stem...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Romaian